Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Total Current Liabilities: 2020-2022

Historic Total Current Liabilities for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2022 value amounting to $22.5 million.

  • Cullinan Therapeutics' Total Current Liabilities fell 13.55% to $23.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $23.4 million, marking a year-over-year decrease of 13.55%. This contributed to the annual value of $22.5 million for FY2022, which is 91.54% up from last year.
  • Per Cullinan Therapeutics' latest filing, its Total Current Liabilities stood at $22.5 million for FY2022, which was up 91.54% from $11.7 million recorded in FY2021.
  • Over the past 5 years, Cullinan Therapeutics' Total Current Liabilities peaked at $22.5 million during FY2022, and registered a low of $11.7 million during FY2021.
  • In the last 3 years, Cullinan Therapeutics' Total Current Liabilities had a median value of $14.3 million in 2020 and averaged $16.2 million.
  • As far as peak fluctuations go, Cullinan Therapeutics' Total Current Liabilities dropped by 17.97% in 2021, and later skyrocketed by 91.54% in 2022.
  • Cullinan Therapeutics' Total Current Liabilities (Yearly) stood at $14.3 million in 2020, then decreased by 17.97% to $11.7 million in 2021, then soared by 91.54% to $22.5 million in 2022.